Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian A Ramshaw

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Expert Review of Vaccines|September 3, 2009
Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunityCharani Ranasinghe, Ian A Ramshaw
European Journal of Immunology|July 8, 2009
Immunisation route-dependent expression of IL-4/IL-13 can modulate HIV-specific CD8(+) CTL avidityCharani Ranasinghe, Ian A Ramshaw
Microbes and Infection|August 28, 2003
Interleukin-4-mediated downregulation of cytotoxic T lymphocyte activity is associated with reduced proliferation of antigen-specific CD8+ T cellsMichael S Rolph, Ian A Ramshaw
Immunity|March 21, 2006
Cytokines, skin, and smallpox-a new link to an antimicrobial PeptideJodie M Harrison, Ian A Ramshaw
Viral Immunology|January 5, 2007
Exploiting 4-1BB costimulation for enhancing antiviral vaccinationJodie M Harrison, Edward M Bertram, Ian A Ramshaw
Immunology and Cell Biology|November 4, 2005
Recombinant fowlpox virus for in vitro gene delivery to pancreatic islet tissueMichelle F Solomon, Ian A Ramshaw, Charmaine J Simeonovic
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Differential effects of the type I interferons alpha4, beta, and epsilon on antiviral activity and vaccine efficacyStephanie L Day, Ian A Ramshaw, Alistair J Ramsay, et al.
Immunology and Cell Biology|October 20, 2010
Human immunodeficiency virus-1 vaccine design: where do we go now?Danushka K Wijesundara, Ronald J Jackson, Ian A Ramshaw, et al.
Vaccine|March 1, 2011
A comparative analysis of HIV-specific mucosal/systemic T cell immunity and avidity following rDNA/rFPV and poxvirus-poxvirus prime boost immunisationsCharani Ranasinghe, Fiona Eyers, John Stambas, et al.
International Immunology|December 26, 2001
Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte populationMarie J Estcourt, Alistair J Ramsay, Andrew Brooks, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Expert Review of Vaccines|September 3, 2009
Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunityCharani Ranasinghe, Ian A Ramshaw
European Journal of Immunology|July 8, 2009
Immunisation route-dependent expression of IL-4/IL-13 can modulate HIV-specific CD8(+) CTL avidityCharani Ranasinghe, Ian A Ramshaw
Microbes and Infection|August 28, 2003
Interleukin-4-mediated downregulation of cytotoxic T lymphocyte activity is associated with reduced proliferation of antigen-specific CD8+ T cellsMichael S Rolph, Ian A Ramshaw
Immunity|March 21, 2006
Cytokines, skin, and smallpox-a new link to an antimicrobial PeptideJodie M Harrison, Ian A Ramshaw
Viral Immunology|January 5, 2007
Exploiting 4-1BB costimulation for enhancing antiviral vaccinationJodie M Harrison, Edward M Bertram, Ian A Ramshaw
Immunology and Cell Biology|November 4, 2005
Recombinant fowlpox virus for in vitro gene delivery to pancreatic islet tissueMichelle F Solomon, Ian A Ramshaw, Charmaine J Simeonovic
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Differential effects of the type I interferons alpha4, beta, and epsilon on antiviral activity and vaccine efficacyStephanie L Day, Ian A Ramshaw, Alistair J Ramsay, et al.
Immunology and Cell Biology|October 20, 2010
Human immunodeficiency virus-1 vaccine design: where do we go now?Danushka K Wijesundara, Ronald J Jackson, Ian A Ramshaw, et al.
Vaccine|March 1, 2011
A comparative analysis of HIV-specific mucosal/systemic T cell immunity and avidity following rDNA/rFPV and poxvirus-poxvirus prime boost immunisationsCharani Ranasinghe, Fiona Eyers, John Stambas, et al.
International Immunology|December 26, 2001
Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte populationMarie J Estcourt, Alistair J Ramsay, Andrew Brooks, et al.
Pageof 3